We are live on ! Find out more
EA

Emerald Advisers Portfolio holdings

AUM $3.16B
1-Year Est. Return 109.58%
This Fund
S&P 500
This Quarter Est. Return
-6.15%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$2.22B
AUM Growth
-$360M
Cap. Flow
-$44.9M
Cap. Flow %
-2.02%
Top 10 Hldgs %
20.17%
Holding
274
New
20
Increased
66
Reduced
133
Closed
31

Top Buys

Rank Stock Value
1
GH icon
Guardant Health
GH
+$22.9M
2
LTH icon
Life Time Group Holdings
LTH
+$19.4M
3
VSEC icon
VSE Corp
VSEC
+$17.6M
4
ETNB
89bio
ETNB
+$13.6M
5
WSBC icon
WesBanco
WSBC
+$12.3M

Sector Composition

Rank Sector Weight
1 Healthcare 25.67%
2 Technology 23.1%
3 Industrials 18.7%
4 Financials 15.06%
5 Consumer Discretionary 7.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LIVN icon
26
LivaNova
LIVN
$4.43B
$29.3M 1.32%
746,513
-6,027
-0.8% -$270K
TBBK icon
27
The Bancorp
TBBK
$2.85B
$29M 1.3%
548,269
+212,102
+63% +$11.8M
AIR icon
28
AAR Corp
AIR
$5.38B
$28.6M 1.29%
510,814
+20,654
+4% +$1.37M
FN icon
29
Fabrinet
FN
$17.1B
$27.6M 1.24%
139,491
+16,490
+13% +$3.6M
RMBS icon
30
Rambus
RMBS
$11B
$27.5M 1.24%
530,702
-13,127
-2% -$771K
AVAV icon
31
AeroVironment
AVAV
$7.2B
$26.8M 1.21%
224,818
+10,808
+5% +$1.66M
LITE icon
32
Lumentum
LITE
$57B
$26.4M 1.19%
424,090
-989
-0.2% -$76.1K
WVE icon
33
Wave Life Sciences
WVE
$1.12B
$25.3M 1.14%
3,133,558
-28,811
-0.9% -$315K
MC icon
34
Moelis & Co
MC
$5.02B
$24.9M 1.12%
426,466
-528
-0.1% -$37.2K
COLL icon
35
Collegium Pharmaceutical
COLL
$1.17B
$24.7M 1.11%
826,475
+14,795
+2% +$452K
GH icon
36
Guardant Health
GH
$20.7B
$22.6M 1.02%
+531,424
New +$22.9M
LPX icon
37
Louisiana-Pacific
LPX
$5.17B
$21.8M 0.98%
237,179
-2,259
-0.9% -$236K
FOUR icon
38
Shift4
FOUR
$3.99B
$21.7M 0.98%
265,422
-48,423
-15% -$4.99M
TENB icon
39
Tenable Holdings
TENB
$4.4B
$21.4M 0.96%
612,040
-3,889
-0.6% -$152K
MOD icon
40
Modine Manufacturing
MOD
$12.2B
$20.1M 0.9%
261,293
-545
-0.2% -$53.7K
LTH icon
41
Life Time Group Holdings
LTH
$9.38B
$19.9M 0.9%
+659,519
New +$19.4M
BJRI icon
42
BJ's Restaurants
BJRI
$1.42B
$19.8M 0.89%
578,327
-5,501
-0.9% -$195K
VSEC icon
43
VSE Corp
VSEC
$5.6B
$19.7M 0.89%
+163,935
New +$17.6M
TREE icon
44
LendingTree
TREE
$645M
$19M 0.86%
378,563
+17,343
+5% +$773K
RARE icon
45
Ultragenyx Pharmaceutical
RARE
$2.88B
$18.7M 0.84%
516,228
-2,100
-0.4% -$87.4K
PDFS icon
46
PDF Solutions
PDFS
$2.14B
$17.7M 0.8%
924,778
+433
+0% +$10.6K
SITM icon
47
SiTime
SITM
$16.6B
$17.6M 0.79%
115,433
+28,393
+33% +$5.45M
MTSI icon
48
MACOM Technology Solutions
MTSI
$20.4B
$17.5M 0.79%
174,654
-5,639
-3% -$686K
EYE icon
49
National Vision
EYE
$1.66B
$17.2M 0.77%
1,343,328
+352,228
+36% +$4.16M
AGYS icon
50
Agilysys
AGYS
$3B
$16.9M 0.76%
233,488
-519
-0.2% -$47.4K

Similar funds

Emerald Advisers's Q1 2025 Portfolio in Review

As of Q1 2025, Emerald Advisers held 274 positions worth $2.22B, down 14% from $2.58B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Emerald Advisers's Q1 2025 filing shows 20 new, 66 increased, 133 reduced and 31 closed positions. Its largest new stake was Guardant Health: 531,424 shares worth $22.6M. The largest sale was Intra-Cellular Therapies Inc., an estimated $36.6M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 24% a quarter earlier, followed by Technology and Industrials.

  • Emerald Advisers's largest Q1 2025 buy was Guardant Health: 531,424 shares worth $22.6M.
  • Emerald Advisers added most to The Bancorp in Q1 2025, an estimated $11.8M increase.
  • Emerald Advisers's biggest Q1 2025 reduction was FTAI Aviation, cutting an estimated $17.2M.
  • Emerald Advisers fully exited Intra-Cellular Therapies Inc. in Q1 2025, selling an estimated $36.6M.
  • Emerald Advisers's ten largest holdings make up 20% of its $2.22B portfolio in Q1 2025.
  • Emerald Advisers opened 20 new positions and closed 31 in Q1 2025.
  • Emerald Advisers's portfolio value fell 14% quarter-over-quarter to $2.22B.

Based on Emerald Advisers's 13F filing for Q1 2025, filed 1 May 2025.